Department of Chinese Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan; School of Post-Baccalaureate Chinese Medicine, Tzu Chi University, Hualien, Taiwan.
Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan; School of Medicine, Tzu-Chi University, Hualien, Taiwan.
Complement Ther Clin Pract. 2019 May;35:208-218. doi: 10.1016/j.ctcp.2019.02.016. Epub 2019 Mar 2.
Chronic obstructive pulmonary disease (COPD) is highly prevalent around the world and has a large impact on its patients, leading to a poor health-related quality of life (HRQL) and exercise capacity. Even under optimal medications, there are still many patients with poor HRQL. Body acupuncture therapy (BAT) is a non-invasive and a popular therapy. Therefore, we aimed to comprehensively analyze the effects of BAT in COPD.
Eight electronic databases were searched. We included randomized controlled trials (RCTs) that evaluated the effect of BAT, medication (M), and pulmonary rehabilitation (PR). The primary outcome was HRQL evaluated by St. George's respiratory questionnaire (SGRQ) or COPD assessment test (CAT).
Of the 922 articles, 12 studies were included with attesting a total of 798 participants. The result obtained indicated a significant improvement that favored the BAT + M group over the M group in CAT scores (MD: -4.77; 95% CI: -6.53 to -3.01; p < 0.00001).
BAT is an effective adjunctive non-pharmacological treatment to improve HRQL in patients under medical treatment for COPD. We suggested that BAT should be considered as one of the methods of management in patients with COPD.
慢性阻塞性肺疾病（COPD）在全球范围内患病率很高，对患者影响很大，导致健康相关生活质量（HRQL）和运动能力较差。即使在最佳药物治疗下，仍有许多患者 HRQL 较差。体针疗法（BAT）是一种非侵入性的流行疗法。因此，我们旨在全面分析 BAT 在 COPD 中的作用。
检索了 8 个电子数据库。我们纳入了评估 BAT、药物（M）和肺康复（PR）效果的随机对照试验（RCT）。主要结局是 St. George's 呼吸问卷（SGRQ）或 COPD 评估测试（CAT）评估的 HRQL。
在 922 篇文章中，有 12 项研究入选，共有 798 名参与者。结果表明，BAT+M 组在 CAT 评分上明显优于 M 组（MD：-4.77；95%CI：-6.53 至-3.01；p<0.00001）。
BAT 是一种有效的辅助非药物治疗方法，可改善接受 COPD 药物治疗患者的 HRQL。我们建议将 BAT 作为 COPD 患者管理方法之一。
